Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2999136556', 'doi': 'https://doi.org/10.1093/ecco-jcc/jjz203.562', 'title': 'P433 A real-world observational study assessing treatment persistence in ulcerative colitis patients receiving anti-TNF treatment (golimumab or adalimumab)', 'display_name': 'P433 A real-world observational study assessing treatment persistence in ulcerative colitis patients receiving anti-TNF treatment (golimumab or adalimumab)', 'publication_year': 2020, 'publication_date': '2020-01-01', 'ids': {'openalex': 'https://openalex.org/W2999136556', 'doi': 'https://doi.org/10.1093/ecco-jcc/jjz203.562', 'mag': '2999136556'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1093/ecco-jcc/jjz203.562', 'pdf_url': 'https://academic.oup.com/ecco-jcc/article-pdf/14/Supplement_1/S394/31851898/jjz203.562.pdf', 'source': {'id': 'https://openalex.org/S2735960814', 'display_name': 'Journal of Crohn s and Colitis', 'issn_l': '1873-9946', 'issn': ['1873-9946', '1876-4479'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310311648', 'host_organization_name': 'Oxford University Press', 'host_organization_lineage': ['https://openalex.org/P4310311647', 'https://openalex.org/P4310311648'], 'host_organization_lineage_names': ['University of Oxford', 'Oxford University Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://academic.oup.com/ecco-jcc/article-pdf/14/Supplement_1/S394/31851898/jjz203.562.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5070403975', 'display_name': 'S Hoque', 'orcid': 'https://orcid.org/0000-0002-1139-6528'}, 'institutions': [{'id': 'https://openalex.org/I225661044', 'display_name': 'Barts Health NHS Trust', 'ror': 'https://ror.org/00b31g692', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I225661044']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'S Hoque', 'raw_affiliation_strings': ['Gastroenterology, Barts Health NHS Trust, London, UK'], 'affiliations': [{'raw_affiliation_string': 'Gastroenterology, Barts Health NHS Trust, London, UK', 'institution_ids': ['https://openalex.org/I225661044']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013999785', 'display_name': 'Simona Boccaletti', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210087189', 'display_name': 'MSD (UK) Limited (United Kingdom)', 'ror': 'https://ror.org/004nn4n27', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155', 'https://openalex.org/I4210087189']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'S Boccaletti', 'raw_affiliation_strings': ['Merck Sharp and Dohme Ltd., Outcomes Research, Hertfordshire, UK'], 'affiliations': [{'raw_affiliation_string': 'Merck Sharp and Dohme Ltd., Outcomes Research, Hertfordshire, UK', 'institution_ids': ['https://openalex.org/I4210087189']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054964075', 'display_name': 'Amy Puenpatom', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'Merck & Co., Inc., Rahway, NJ, USA (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'A Puenpatom', 'raw_affiliation_strings': ['Merck and Co.- Inc., Outcomes Research, New Jersey, USA'], 'affiliations': [{'raw_affiliation_string': 'Merck and Co.- Inc., Outcomes Research, New Jersey, USA', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5032509872', 'display_name': 'Caroline T. Brown', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210087189', 'display_name': 'MSD (UK) Limited (United Kingdom)', 'ror': 'https://ror.org/004nn4n27', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155', 'https://openalex.org/I4210087189']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'C Brown', 'raw_affiliation_strings': ['Merck Sharp and Dohme Ltd., Outcomes Research, Hertfordshire, UK'], 'affiliations': [{'raw_affiliation_string': 'Merck Sharp and Dohme Ltd., Outcomes Research, Hertfordshire, UK', 'institution_ids': ['https://openalex.org/I4210087189']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001993231', 'display_name': 'Christopher M. Black', 'orcid': 'https://orcid.org/0000-0003-2934-108X'}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'Merck & Co., Inc., Rahway, NJ, USA (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'C Black', 'raw_affiliation_strings': ['Merck and Co.- Inc., Outcomes Research, New Jersey, USA'], 'affiliations': [{'raw_affiliation_string': 'Merck and Co.- Inc., Outcomes Research, New Jersey, USA', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042566782', 'display_name': 'Jenna Roberts', 'orcid': 'https://orcid.org/0000-0001-6959-3025'}, 'institutions': [{'id': 'https://openalex.org/I4210091464', 'display_name': 'Adelphi Group (United Kingdom)', 'ror': 'https://ror.org/00egpfv87', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I4210091464']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'J Roberts', 'raw_affiliation_strings': ['Adelphi Real World, Observational Research, Manchester, UK'], 'affiliations': [{'raw_affiliation_string': 'Adelphi Real World, Observational Research, Manchester, UK', 'institution_ids': ['https://openalex.org/I4210091464']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022862168', 'display_name': 'Ivana Rajkovic', 'orcid': 'https://orcid.org/0000-0002-1924-7922'}, 'institutions': [{'id': 'https://openalex.org/I4210091464', 'display_name': 'Adelphi Group (United Kingdom)', 'ror': 'https://ror.org/00egpfv87', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I4210091464']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'I Rajkovic', 'raw_affiliation_strings': ['Adelphi Real World, Observational Research, Manchester, UK'], 'affiliations': [{'raw_affiliation_string': 'Adelphi Real World, Observational Research, Manchester, UK', 'institution_ids': ['https://openalex.org/I4210091464']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5033267783', 'display_name': 'Gary Milligan', 'orcid': 'https://orcid.org/0000-0002-1427-3339'}, 'institutions': [{'id': 'https://openalex.org/I4210091464', 'display_name': 'Adelphi Group (United Kingdom)', 'ror': 'https://ror.org/00egpfv87', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I4210091464']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'G Milligan', 'raw_affiliation_strings': ['Adelphi Real World, Observational Research, Manchester, UK'], 'affiliations': [{'raw_affiliation_string': 'Adelphi Real World, Observational Research, Manchester, UK', 'institution_ids': ['https://openalex.org/I4210091464']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 4, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3881, 'currency': 'EUR', 'value_usd': 4185, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 60}, 'biblio': {'volume': '14', 'issue': 'Supplement_1', 'first_page': 'S394', 'last_page': 'S394'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10134', 'display_name': 'Inflammatory Bowel Disease', 'score': 0.9976, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10134', 'display_name': 'Inflammatory Bowel Disease', 'score': 0.9976, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12255', 'display_name': 'Biosimilars and Bioanalytical Methods', 'score': 0.9862, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10038', 'display_name': 'Tuberculosis Research and Epidemiology', 'score': 0.9726, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/golimumab', 'display_name': 'Golimumab', 'score': 0.9939378}], 'concepts': [{'id': 'https://openalex.org/C2781290027', 'wikidata': 'https://www.wikidata.org/wiki/Q413879', 'display_name': 'Golimumab', 'level': 4, 'score': 0.9939378}, {'id': 'https://openalex.org/C2780132546', 'wikidata': 'https://www.wikidata.org/wiki/Q348260', 'display_name': 'Adalimumab', 'level': 3, 'score': 0.97150695}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8015746}, {'id': 'https://openalex.org/C2780479503', 'wikidata': 'https://www.wikidata.org/wiki/Q1477', 'display_name': 'Ulcerative colitis', 'level': 3, 'score': 0.67362016}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.47998616}, {'id': 'https://openalex.org/C2776667177', 'wikidata': 'https://www.wikidata.org/wiki/Q1779148', 'display_name': 'Colectomy', 'level': 4, 'score': 0.419073}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.0746735}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.06325245}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1093/ecco-jcc/jjz203.562', 'pdf_url': 'https://academic.oup.com/ecco-jcc/article-pdf/14/Supplement_1/S394/31851898/jjz203.562.pdf', 'source': {'id': 'https://openalex.org/S2735960814', 'display_name': 'Journal of Crohn s and Colitis', 'issn_l': '1873-9946', 'issn': ['1873-9946', '1876-4479'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310311648', 'host_organization_name': 'Oxford University Press', 'host_organization_lineage': ['https://openalex.org/P4310311647', 'https://openalex.org/P4310311648'], 'host_organization_lineage_names': ['University of Oxford', 'Oxford University Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1093/ecco-jcc/jjz203.562', 'pdf_url': 'https://academic.oup.com/ecco-jcc/article-pdf/14/Supplement_1/S394/31851898/jjz203.562.pdf', 'source': {'id': 'https://openalex.org/S2735960814', 'display_name': 'Journal of Crohn s and Colitis', 'issn_l': '1873-9946', 'issn': ['1873-9946', '1876-4479'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310311648', 'host_organization_name': 'Oxford University Press', 'host_organization_lineage': ['https://openalex.org/P4310311647', 'https://openalex.org/P4310311648'], 'host_organization_lineage_names': ['University of Oxford', 'Oxford University Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.82, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4248080310', 'https://openalex.org/W31124029', 'https://openalex.org/W2999136556', 'https://openalex.org/W2809113401', 'https://openalex.org/W2611448469', 'https://openalex.org/W2404327936', 'https://openalex.org/W2339769921', 'https://openalex.org/W2327255580', 'https://openalex.org/W2137530185', 'https://openalex.org/W2062990906'], 'abstract_inverted_index': {'Abstract': [0], 'Background': [1], 'There': [2], 'are': [3], 'limited': [4], 'published': [5, 29], 'observational': [6], 'data': [7, 135, 146, 309], 'describing': [8, 85], 'both': [9], 'clinical': [10, 35, 42], 'outcomes': [11, 32, 61], 'and': [12, 59, 64, 89, 113, 120, 138, 158, 194, 229, 257, 283, 294], 'treatment': [13, 55, 87, 115, 171, 236, 251, 316, 326], 'persistence': [14, 218, 317], 'rates': [15], 'for': [16, 25, 93, 136, 318], 'anti-TNFs': [17], 'used': [18, 166], 'to': [19, 128, 153, 156, 161, 167, 261], 'treat': [20], 'ulcerative': [21], 'colitis': [22], '(UC),': [23], 'particularly': [24], 'golimumab.': [26], 'Based': [27], 'on': [28, 235], 'literature': [30], 'the': [31, 45, 67, 82, 145, 169, 246, 271], 'demonstrated': [33, 290], 'in': [34, 66, 81, 311], 'trials': [36], 'do': [37], 'not': [38], 'necessarily': [39], 'translate': [40], 'into': [41], 'practice,': [43], 'highlighting': [44], 'importance': [46], 'of': [47, 134, 176, 210, 227, 231, 296], 'real-world': [48, 68, 308], 'studies.': [49], 'In': [50], 'this': [51, 312], 'study,': [52], 'we': [53], 'evaluated': [54], 'persistence,': [56], 'switching': [57], 'patterns,': [58], 'colectomy': [60, 90], 'between': [62, 116], 'golimumab': [63, 99, 105, 220, 228, 256, 293, 319], 'adalimumab': [65, 107, 222, 232, 259, 297, 322], 'setting.': [69], 'Methods': [70], 'A': [71, 174], 'retrospective': [72], 'chart': [73], 'review': [74], 'was': [75, 151, 185, 270, 289, 330], 'conducted': [76, 152], 'across': [77], '16': [78], 'NHS': [79], 'sites': [80], 'UK.': [83], 'Data': [84], 'demographics,': [86], 'history': [88], 'were': [91, 103, 126, 139, 147, 165, 196, 202, 212, 223], 'collected': [92, 310], 'UC': [94], 'patients': [95, 211, 233, 248, 266, 298], 'treated': [96], 'with': [97, 219, 321], 'either': [98], 'or': [100, 106, 110, 221], 'adalimumab.': [101], 'Patients': [102, 124], 'receiving': [104, 213], 'as': [108], 'first': [109], 'second-line': [111], 'therapy': [112], 'initiating': [114], '1': [117, 334], 'March': [118], '2016': [119], '30': [121], 'September': [122], '2017.': [123], 'enrolled': [125], 'required': [127], 'have': [129], 'at': [130, 237], 'least': [131], '6': [132], 'months': [133, 143, 239, 300, 324], 'analyses,': [137], 'followed': [140, 277], 'within': [141, 252, 333], '12': [142, 238, 253, 299, 323], 'where': [144], 'available.': [148], 'Kaplan–Meier': [149], 'analysis': [150], 'assess': [154], 'time': [155, 160], 'discontinuation': [157], 'also': [159], 'colectomy;': [162], 'log-rank': [163], 'tests': [164], 'compare': [168], 'two': [170], 'arms.': [172], 'Results': [173], 'total': [175], '183': [177], 'patients,': [178], '(87': [179], 'golimumab,': [180], '96': [181], 'adalimumab),': [182, 201], 'mean': [183], 'age': [184], '45.6': [186], 'years': [187, 189, 192], '(46.8': [188], 'golimumab;': [190, 199, 207], '44.4': [191], 'adalimumab)': [193, 209], '59.6%': [195], 'male': [197], '(71.3%': [198], '49.0%': [200], 'included.': [203], 'Overall,': [204], '79.8%': [205], '(78.2%': [206], '81.3%': [208], 'their': [214], 'first-line': [215], 'biologic.': [216, 263], 'Treatment': [217], 'relatively': [224, 331], 'similar;': [225], '64.4%': [226], '64.6%': [230], 'remaining': [234], '(p': [240, 303], '=': [241, 304], '0.7,': [242], 'Figure': [243], '1).': [244], 'Of': [245, 264], '65': [247], 'who': [249, 267], 'discontinued': [250], 'months,': [254], '48.4%': [255], '64.7%': [258], 'switched': [260], 'another': [262], 'those': [265], 'switched,': [268], 'vedolizumab': [269], 'most': [272], 'commonly': [273], 'prescribed': [274], 'drug': [275], '(56.8%),': [276], 'by': [278, 291], 'infliximab': [279, 284], 'biosimilar': [280], '(Inflectra/Remsima)': [281], '(29.7%)': [282], '(Remicade)': [285], '(13.5%).': [286], 'Colectomy-free': [287, 328], 'survival': [288, 329], '92.0%': [292], '91.7%': [295], 'post-treatment': [301], 'initiation': [302], '0.7).': [305], 'Conclusion': [306], 'The': [307], 'study': [313], 'demonstrate': [314], 'comparable': [315], 'compared': [320], 'following': [325], 'initiation.': [327], 'similar': [332], 'year.': [335]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2999136556', 'counts_by_year': [], 'updated_date': '2024-12-29T11:25:45.085527', 'created_date': '2020-01-23'}